Cargando…
Microglial cGAS drives neuroinflammation in the MPTP mouse models of Parkinson's disease
BACKGROUND: Neuroinflammation has been widely accepted as a cause of the degenerative process. Increasing interest has been devoted to developing intervening therapeutics for preventing neuroinflammation in Parkinson's disease (PD). It is well known that virus infections, including DNA viruses,...
Autores principales: | Ma, Chunmei, Liu, Ying, Li, Sheng, Ma, Chanyuan, Huang, Jiajia, Wen, Shuang, Yang, Shuo, Wang, Bingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324349/ https://www.ncbi.nlm.nih.gov/pubmed/36914567 http://dx.doi.org/10.1111/cns.14157 |
Ejemplares similares
-
GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease
por: Wang, Bingwei, et al.
Publicado: (2023) -
RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
por: Kim, Do-Yeon, et al.
Publicado: (2023) -
Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation
por: Ma, Chunmei, et al.
Publicado: (2020) -
Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson’s Disease Mice
por: Yan, Aijuan, et al.
Publicado: (2019) -
“Effect of valerenic acid on neuroinflammation in a MPTP-induced mouse model of Parkinson’s disease”
por: Rodríguez-Cruz, Alfredo, et al.
Publicado: (2019)